We recently published 11 Stocks Crushing Wall Street With Whopping Gains. GSK plc (NYSE:GSK) is one of the top performers on Tuesday. Shares of GSK rallied for a third straight day on Tuesday to hit a ...

GSK CEO Emma Walmsley will step down in 2025, with Luke Miels taking over as the company refocuses on pipeline growth and Montco operations.

The U.S. Supreme Court is allowing Federal Reserve Governor Lisa Cook to remain in her position until oral arguments are ...

Emma Walmsley was the first woman to hold the CEO post at the Big Pharma company.

GSK is "betting big on the US" and engaged in "constructive" talks on drug pricing with President Donald Trump's ...

M&A headlined for a second straight week as Genmab acquired Merus for $8 billion; Pfizer strikes most-favored-nation deal ...

GSK Plc is “betting big on the US” and engaged in constructive talks on drug pricing with US President Donald Trump’s administration, according to Emma Walmsley, the outgoing chief executive officer ...

One change she made inside her bank is making the company a flatter structure where no one -- not even the top executives -- have fancy office spaces. It’s all just a basic glass office. This was a ...

Stocks closed higher Monday, rebounding after a losing week, but the dollar and Treasury yields fell on fears of a possible ...

Eleven stocks were on a high note on Tuesday, dominated by US pharmaceutical companies, as investors began loading portfolios ...

Luke Miels, GSK’s chief commercial officer, has been appointed CEO designate and will take over as chief executive on Jan. 1, 2026.

GSK's Emma Walmsley steps down, Luke Miels appointed CEO amid pipeline challenges. Kala Bio halts drug development causing ...